Peptides & the FDA review: your questions, answered

The FDA-evaluated uses listed for Semax are cerebral ischemia, migraine, and trigeminal neuralgia.¹

No. Approval by another country's regulator does not confer FDA approval or U.S. legal status. The FDA evaluates the evidence independently.²

Semax is not FDA-approved and has no cleared compounding pathway in the U.S. It was in Category 2 of the interim 503A list, then removed in April 2026 and referred to the July 2026 advisory committee. Its approval in Russia does not make it approved here.^{1 3 4}